Managing Vancomycin Dosage in Patients with Elevated Creatinine
Initial Dosage Adjustment Based on Renal Function
- The American College of Physicians and other medical societies recommend that when creatinine is elevated, immediately reduce the vancomycin dose or extend the dosing interval based on creatinine clearance, and hold the next dose if trough levels exceed 20 mg/L, to prevent nephrotoxicity in patients with impaired renal function 1
Trough Monitoring Strategy
- Target trough levels of 15-20 mg/L for serious infections, such as bacteremia, endocarditis, osteomyelitis, meningitis, and hospital-acquired pneumonia, as recommended by the Infectious Diseases Society of America 2, 1
- Monitor trough levels before each dose adjustment and at least twice weekly throughout therapy, as suggested by the American College of Clinical Pharmacy 1
Management of Elevated Trough Levels
- If trough exceeds 20 mg/L, immediately hold the next scheduled dose and recheck the trough before administering any subsequent doses, as recommended by the American College of Clinical Pharmacy 1
- Once trough decreases to 15-20 mg/L, resume vancomycin at a reduced dose or extend the dosing interval, as suggested by the American College of Clinical Pharmacy 1
- Monitor serum creatinine at least twice weekly for nephrotoxicity, defined as ≥2-3 consecutive increases of 0.5 mg/dL or 150% from baseline, as recommended by the National Kidney Foundation and the Infectious Diseases Society of America 2, 1
Critical Pitfalls to Avoid
- Never use standard nomograms in renal impairment, as they were not designed to achieve current therapeutic targets and will result in overdosing, as warned by the Infectious Diseases Society of America 2
- Never continue the same dose when trough exceeds 20 mg/L, as this dramatically increases nephrotoxicity risk, as cautioned by the American College of Clinical Pharmacy 1
- Never monitor peak levels, as this provides no clinical value and is not recommended, as stated by the Infectious Diseases Society of America and the American College of Clinical Pharmacy 2, 1